Dr. Handelsman describes metabolic syndrome, which places patients at an increased risk for coronary artery disease and type 2 diabetes says the American Heart Association.
About Dr. Yehuda Handelsman, M.D.:
Dr. Yehuda Handelsman is an endocrinologist in solo practice in Tarzana, California; Medical Director, Metabolic Institute of America; and Senior Scientific Consultant, Metabolic Endocrine Education Foundation. He is a summa cum laude graduate of the University of the Pacific, Stockton, California, and a fellow of the American College of Endocrinology and the American College of Physicians. Dr. Handelsman obtained his MD from Tel Aviv University, Israel; residency in internal medicine at New York Infirmary Beekman Downtown Hospital - New York University, New York; and fellowship in diabetes and endocrinology, University of Southern California Medical School, Los Angeles. Currently, he is Secretary of AACE and a member of the Executive Committee.